文献速递肿瘤 PET/CT骨显像与常规 SPECT

全身动态[18F]FDG-PET/CT在巨细胞动脉炎与风湿性多肌痛中的应用

Whole-body Dynamic [18F]FDG-PET/CT in Giant Cell Arteritis and Polymyalgia Rheumatica.
PubMed 文献 · Clin Nucl Med · 2026-03-10

该单中心前瞻性研究纳入25例疑似巨细胞动脉炎(GCA)和/或风湿性多肌痛(PMR)患者,采用多床位多通道动态全身采集方案行[18F]FDG-PET/CT,基于Patlak分析生成MRFDG图像。动态PET与静态PET的靶本比(TBR)差异在两种疾病中均有统计学意义(GCA P<0.003,PMR P<0.003),且两种疾病中动态与静态PET的TBR均显著高于健康对照。

要点

  • 动态全身[18F]FDG-PET/CT在GCA和PMR中TBR显著高于标准静态PET。
  • 动态与静态PET的TBR差异在GCA和PMR中均有统计学意义(均P<0.003)。

核心结论

  • 全身动态[18F]FDG-PET/CT在GCA和PMR患者中提供的TBR显著高于标准静态PET成像。
  • 全身动态[18F]FDG-PET/CT可能有助于提高检测GCA和PMR的诊断准确性。

研究设计与样本

  • 单中心前瞻性研究纳入25例疑似GCA和/或PMR患者,治疗前使用标准PET/CT扫描仪行多床位多通道动态全身采集(dPET)。
  • 基于标准Patlak分析重建生成[18F]FDG代谢率(MRFDG)图像,以除外dPET的可用影像和实验室结果作为参考标准。

主要发现

  • 动态PET与静态PET的TBR差异在GCA中P<0.003、在PMR中P<0.003。
  • GCA和PMR中动态PET与静态PET的TBR均显著高于健康对照。

关键数值与推荐

  • 病理性FDG摄取时,在血管壁和关节放置VOI进行定量,TBR定义为血管壁和关节VOI最大值与血池VOI均值之比(GCA)或与正常肌肉VOI均值之比(PMR)。

临床怎么用

  • 对疑似GCA和/或PMR患者,可考虑采用全身动态[18F]FDG-PET/CT采集以提高病变与背景的对比度。

局限性

  • 单中心研究,样本量25例,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to explore the diagnostic efficacy of whole-body dynamic (WBD) acquisition using [18F]-Fluorodeoxyglucose-positron-emission-tomography/computed-tomography ([18F]FDG-PET/CT) for the assessment of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) compared with the standard static PET/CT. METHODS: Twenty-five patients with suspected GCA and/or PMR were prospectively enrolled in this single-center study. WBD PET imaging was performed before treatment using a standard PET/CT scanner with a multibed multipass dynamic whole-body acquisition approach (dPET). Reconstructed datasets were used to generate metabolic rate of [18F]FDG (MRFDG) images based on standard Patlak analysis. In case of pathologic FDG uptake, VOIs placed in vessel walls and joints were used for quantitation and definition of the target-to-background ratio (TBR): uptake in VOIs of vessel walls and joints (maximum values), to VOIs in blood pool (GCA), or to VOIs in normal muscles (PMR) (mean values). The final diagnosis based on the available imaging and laboratory results (except dPET), served as the standard of reference. RESULTS: Seventeen of the 25 patients (68%) showed pathologic FDG uptake, of which 5 (20%) were finally diagnosed with GCA alone, 6 (24%) with PMR alone, and another 6 (24%) with both conditions. TBR difference between dPET and static PET was significant in both diseases(GCA P<0.003, PMR P<0.003), and TBRs of dPET and static PET were significantly higher in both diseases compared with the healthy controls. CONCLUSIONS: WBD [18F]FDG-PET/CT provided a significantly higher TBR in patients with GCA and PMR compared with standard static PET imaging. WBD [18F]FDG-PET/CT may potentially enhance the diagnostic accuracy in detecting GCA and PMR.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sah BR, Eyrikh A, Husmann L, et al. Whole-body Dynamic [18F]FDG-PET/CT in Giant Cell Arteritis and Polymyalgia Rheumatica. Clin Nucl Med. 2026. PMID: 42081700. doi:10.1097/RLU.0000000000006369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。